Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

BACKGROUND. Conflicting data exist regarding the prognostic impact of the isocitrate dehydrogenase (IDH) mutation in intrahepatic cholangiocarcinoma (ICC), and limited data exist in patients with advanced-stage disease. Similarly, the clinical phenotype of patients with advanced IDH mutant (IDHm) IC...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Goyal, Lipika, Govindan, Aparna, Sheth, Rahul A., Nardi, Valentina, Blaszkowsky, Lawrence S., Faris, Jason E., Clark, Jeffrey W., Ryan, David P., Kwak, Eunice L., Allen, Jill N., Murphy, Janet E., Saha, Supriya K., Hong, Theodore S., Wo, Jennifer Y., Ferrone, Cristina R., Tanabe, Kenneth K., Chong, Dawn Q., Deshpande, Vikram, Borger, Darrell R., Iafrate, A. John, Bardeesy, Nabeel, Zheng, Hui, Zhu, Andrew X.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2015
Onderwerpen:
Gastrointestinal Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571807/
https://ncbi.nlm.nih.gov/pubmed/26245674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0210
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items